Quick Answer
UTAH MEDICAL PRODUCTS INC reported Total Revenue of $38.52 million for fiscal year 2025.
UTAH MEDICAL PRODUCTS INC — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $38.52M -5.8% |
$40.90M -18.6% |
$50.22M -3.9% |
$52.28M +6.6% |
$49.05M +16.3% |
$42.18M -10.1% |
| Revenue (ASC 606) | $38.52M -5.8% |
$40.90M -18.6% |
$50.22M -3.9% |
$52.28M +6.6% |
$49.05M +16.3% |
$42.18M -10.1% |
| Diluted EPS | $3.48 -12.1% |
$3.96 -13.3% |
$4.57 +1.1% |
$4.52 +11.9% |
$4.04 +37.4% |
$2.94 -25.4% |
| Total Assets | $122.54M +0.0% |
$122.54M -9.5% |
$135.46M +9.4% |
$123.87M +7.1% |
$115.64M +3.5% |
$111.75M +1.8% |
| Cash and Equivalents | $85.76M +3.4% |
$82.98M -10.7% |
$92.87M +23.7% |
$75.05M +23.1% |
$60.97M +18.2% |
$51.59M +20.6% |
| Stockholders Equity | $119.27M +1.6% |
$117.43M -8.5% |
$128.31M +12.3% |
$114.25M +6.6% |
$107.14M +4.2% |
$102.82M +1.7% |
| R&D Expense | $668.0K -17.8% |
$813.0K +45.2% |
$560.0K +13.6% |
$493.0K -6.3% |
$526.0K +8.2% |
$486.0K +0.6% |
| Operating Income | $11.40M -16.1% |
$13.59M -19.0% |
$16.78M -15.2% |
$19.79M +4.8% |
$18.88M +37.7% |
$13.71M -22.3% |
| Gross Profit | $22.00M -8.9% |
$24.14M -19.6% |
$30.04M -6.7% |
$32.20M +4.1% |
$30.92M +21.0% |
$25.55M -13.3% |
| Shares Outstanding | 3.19M -4.5% |
3.33M -8.1% |
3.63M +0.1% |
3.63M -0.7% |
3.65M +0.3% |
3.64M -2.1% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $9.81M | -1.9% | -1.4% |
| Revenue (ASC 606) | September 30, 2025 | $9.81M | -1.9% | -1.4% |
| Diluted EPS | September 30, 2025 | $0.82 | -19.6% | -12.8% |
| Total Assets | September 30, 2025 | $121.97M | -6.0% | +1.0% |
| Cash and Equivalents | September 30, 2025 | $84.27M | -4.7% | +2.5% |
| Stockholders Equity | September 30, 2025 | $118.25M | -4.8% | +0.6% |
| R&D Expense | September 30, 2025 | $167.0K | -2.9% | +23.7% |
| Operating Income | September 30, 2025 | $2.61M | -21.9% | -18.3% |
| Gross Profit | September 30, 2025 | $5.60M | -3.4% | +0.2% |
| Shares Outstanding | September 30, 2025 | 3.20M | -6.9% | -0.4% |
- UTAH MEDICAL PRODUCTS INC reported Total Revenue of $38.52 million for fiscal year 2025.
- UTAH MEDICAL PRODUCTS INC showed a decrease of -5.8% in Total Revenue compared to the prior fiscal year.
- UTAH MEDICAL PRODUCTS INC reported Revenue (ASC 606) of $38.52 million for fiscal year 2025.
- UTAH MEDICAL PRODUCTS INC showed a decrease of -5.8% in Revenue (ASC 606) compared to the prior fiscal year.
- UTAH MEDICAL PRODUCTS INC reported Diluted EPS of $3.48 per share for fiscal year 2025.
- UTAH MEDICAL PRODUCTS INC showed a decrease of -12.1% in Diluted EPS compared to the prior fiscal year.
- UTAH MEDICAL PRODUCTS INC reported Total Assets of $122.54 million for fiscal year 2025.
- UTAH MEDICAL PRODUCTS INC showed an increase of +0.0% in Total Assets compared to the prior fiscal year.
- UTAH MEDICAL PRODUCTS INC reported Cash and Equivalents of $85.76 million for fiscal year 2025.
- UTAH MEDICAL PRODUCTS INC showed an increase of +3.4% in Cash and Equivalents compared to the prior fiscal year.
- UTAH MEDICAL PRODUCTS INC reported Stockholders Equity of $119.27 million for fiscal year 2025.
- UTAH MEDICAL PRODUCTS INC showed an increase of +1.6% in Stockholders Equity compared to the prior fiscal year.
- UTAH MEDICAL PRODUCTS INC reported R&D Expense of $668.0 thousand for fiscal year 2025.
- UTAH MEDICAL PRODUCTS INC showed a decrease of -17.8% in R&D Expense compared to the prior fiscal year.
- UTAH MEDICAL PRODUCTS INC reported Operating Income of $11.40 million for fiscal year 2025.
- UTAH MEDICAL PRODUCTS INC showed a decrease of -16.1% in Operating Income compared to the prior fiscal year.
- UTAH MEDICAL PRODUCTS INC reported Gross Profit of $22.00 million for fiscal year 2025.
- UTAH MEDICAL PRODUCTS INC showed a decrease of -8.9% in Gross Profit compared to the prior fiscal year.
- UTAH MEDICAL PRODUCTS INC reported Shares Outstanding of 3.19 million shares for fiscal year 2025.
- UTAH MEDICAL PRODUCTS INC showed a decrease of -4.5% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: